{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:06:59Z","timestamp":1790946419334,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09,201(0423)\/ 18 EMR-I"],"award-info":[{"award-number":["09,201(0423)\/ 18 EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11010-020-03758-y","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T17:02:47Z","timestamp":1591894967000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats"],"prefix":"10.1007","volume":"471","author":[{"given":"Divya","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldho","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Ananthapadmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathinavel","family":"Andiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6800-2104","authenticated-orcid":false,"given":"Selvam Govindan","family":"Sadasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"3758_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE (2017) IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40\u201350","journal-title":"Diabetes Res Clin Pract"},{"key":"3758_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"N Cho","year":"2018","unstructured":"Cho N, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, OhlroggeMalanda AWB (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271\u2013281","journal-title":"Diabetes Res Clin Pract"},{"key":"3758_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.diabres.2017.04.010","volume":"128","author":"D Sharma","year":"2017","unstructured":"Sharma D, Bhattacharya P, Kalia K, Tiwari V (2017) Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets. Diabetes Res Clin Pract 128:91\u2013108","journal-title":"Diabetes Res Clin Pract"},{"key":"3758_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AK Lim","year":"2014","unstructured":"Lim AK (2014) Diabetic nephropathy\u2013complications and treatment. Int J Nephrol Renovasc Dis 7:361\u2013381","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"3758_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5455\/ijmsph.2012.1.59-70","volume":"1","author":"DN Parchwani","year":"2012","unstructured":"Parchwani DN, Upadhyah AA (2012) Diabetic nephropathy: progression and pathophysiology. Int J Med Sci Public Health 1:59\u201370","journal-title":"Int J Med Sci Public Health"},{"key":"3758_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.12250","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu Q, Wang S, Cai L (2014) Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Investig 5:623\u2013634","journal-title":"J Diabetes Investig"},{"key":"3758_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_1.29","volume":"17","author":"GM London","year":"2002","unstructured":"London GM (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17:29\u201336","journal-title":"Nephrol Dial Transplant"},{"key":"3758_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.02.047","volume":"53","author":"FG Hage","year":"2009","unstructured":"Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE (2009) The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 53:2129\u20132140","journal-title":"J Am Coll Cardiol"},{"key":"3758_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ecl.2006.09.006","volume":"35","author":"AE Kitabchi","year":"2006","unstructured":"Kitabchi AE, Nyenw EA (2006) Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin 35:725\u2013751","journal-title":"Endocrinol Metab Clin"},{"issue":"4","key":"3758_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/met.2010.0108","volume":"9","author":"G Souto","year":"2011","unstructured":"Souto G, Donapetry C, Calvino J, Adeva MM (2011) Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metab Syndr Relat Disord 9(4):247\u2013253","journal-title":"Metab Syndr Relat Disord"},{"key":"3758_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrneph.2010.33","volume":"6","author":"JA Kraut","year":"2010","unstructured":"Kraut JA, Madias NE (2010) Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6:274\u2013285","journal-title":"Nat Rev Nephrol"},{"key":"3758_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-cellbio-100109-104020","volume":"26","author":"P Singh","year":"2010","unstructured":"Singh P, Carraher C, Schwarzbauer JE (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26:397\u2013419","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3758_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40620-018-0493-3","volume":"31","author":"G Tammaro","year":"2018","unstructured":"Tammaro G, Zacchia M, Zona E, Zacchia E, Capasso G (2018) Acute and chronic effects of metabolic acidosis on renal function and structure. J Nephrol 31:551\u2013559","journal-title":"J Nephrol"},{"key":"3758_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3904\/kjim.2016.174","volume":"32","author":"Y Kim","year":"2017","unstructured":"Kim Y, Park CW (2017) New therapeutic agents in diabetic nephropathy. Korean J Intern Med 32:11\u201325","journal-title":"Korean J Intern Med"},{"key":"3758_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1681\/ASN.2014020205","volume":"26","author":"M Dobre","year":"2015","unstructured":"Dobre M, Rahman M, Hostette TH (2015) Current status of bicarbonate in CKD. J Am Soc Nephrol 26:515\u2013523","journal-title":"J Am Soc Nephrol"},{"key":"3758_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrd.2016.67","volume":"15","author":"MD Breyer","year":"2016","unstructured":"Breyer MD, Susztak K (2016) The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov 15:568\u2013588","journal-title":"Nat Rev Drug Discov"},{"key":"3758_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1476-511X-13-184","volume":"13","author":"IB Gomes","year":"2014","unstructured":"Gomes IB, Porto ML, Santos MCL, Campagnaro BP, Pereira TM, Meyrelles SS, Vasquez EC (2014) Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL\/6J model of diabetic nephropathy. Lipids Health Dis 13:184\u2013187","journal-title":"Lipids Health Dis"},{"key":"3758_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3892\/etm.2014.2090","volume":"9","author":"YB Wang","year":"2015","unstructured":"Wang YB, Ge ZM, Kang WQ, Lian ZX, Yao J, Zhou CY (2015) Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes. Exp Ther Med 9:451\u2013455","journal-title":"Exp Ther Med"},{"key":"3758_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3892\/etm.2017.4509","volume":"14","author":"CS Han","year":"2017","unstructured":"Han CS, Liu K, Zhang N, Li SW, Gao HC (2017) Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy. Exp Ther Med 14:181\u2013186","journal-title":"Exp Ther Med"},{"key":"3758_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1515\/CCLM.2005.123","volume":"43","author":"J Penders","year":"2005","unstructured":"Penders J, Fiers T, Giri M, Wuyts B, Ysewyn L, Delanghe JR (2005) Quantitative measurement of ketone bodies in urine using reflectometry. Clin Chem Lab Med 43:724\u2013729","journal-title":"Clin Chem Lab Med"},{"key":"3758_CR21","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0735-1097(03)00403-0","volume":"41","author":"JE Liu","year":"2003","unstructured":"Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB (2003) Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 41:2022\u20132028","journal-title":"J Am Coll Cardiol"},{"key":"3758_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","volume":"160","author":"TK Ma","year":"2010","unstructured":"Ma TK, Kam KK, Yan BP, Lam YY (2010) Renin\u2013angiotensin\u2013aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160:1273\u20131292","journal-title":"Br J Pharmacol"},{"key":"3758_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cbin.10752","volume":"41","author":"MA Abdel Aziz","year":"2017","unstructured":"Abdel Aziz MA, Badary DM, Hussein MRA (2017) Renal damage following Alloxan-induced diabetes is associated with generation of reactive oxygen species, alterations of p53, TGF-\u03b21, and extracellular matrix metalloproteinases in rats. Cell Biol Int 41:525\u2013533","journal-title":"Cell Biol Int"},{"key":"3758_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5487\/TR.2013.29.1.015","volume":"29","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Ha BJ (2014) Antihyperglycemic and antihyperlipidemic effects of fermented Rhynchosia nulubilis in alloxan-induced diabetic rats. Toxicol Res 29:15\u201319","journal-title":"Toxicol Res"},{"key":"3758_CR25","first-page":"19","volume":"9","author":"HY Bako","year":"2014","unstructured":"Bako HY, Mohammad JS, Wazir PM, Bulus T, Gwarzo MY, Zubairu MM (2014) Lipid profile of alloxan-induced diabetic wistar rats treated with methanolic extract of Adansonia digitata fruit pulp. Sci World J 9:19\u201324","journal-title":"Sci World J"},{"key":"3758_CR26","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.biopha.2016.10.080","volume":"84","author":"A Ramakrishnan","year":"2016","unstructured":"Ramakrishnan A, Vijayakumar N, Renuka M (2016) Naringin regulates glutamate-nitric oxide cGMP pathway in ammonium chloride induced neurotoxicity. Biomed Pharmacother 84:1717\u20131726","journal-title":"Biomed Pharmacother"},{"key":"3758_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","volume":"25","author":"A Ganeshpurkar","year":"2017","unstructured":"Ganeshpurkar A, Saluja AK (2017) The pharmacological potential of rutin. Saudi Pharm J 25:149\u2013164","journal-title":"Saudi Pharm J"},{"key":"3758_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2215\/CJN.03020906","volume":"2","author":"JA Kraut","year":"2007","unstructured":"Kraut JA, Madias NE (2007) Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2:162\u2013174","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3758_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ijms20020366","volume":"20","author":"J He","year":"2019","unstructured":"He J, Yang B (2019) Aquaporins in renal diseases. Int J Mol Sci 20(2):366","journal-title":"Int J Mol Sci"},{"key":"3758_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1159\/000323984","volume":"26","author":"M Nowik","year":"2010","unstructured":"Nowik M, Kampik NB, Mihailova M, Eladari D, Wagner CA (2010) Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats\u2013species differences and technical considerations. Cell Physiol Biochem 26:1059\u20131072","journal-title":"Cell Physiol Biochem"},{"key":"3758_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/ajpcell.00394.2003","volume":"286","author":"H Amlal","year":"2004","unstructured":"Amlal H, Sheriff S, Soleimani M (2004) Upregulation of collecting duct aquaporin-2 by metabolic acidosis: role of vasopressin. Am J Physiol Cell Physiol 286:1019\u20131030","journal-title":"Am J Physiol Cell Physiol"},{"key":"3758_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000452725","volume":"43","author":"T Dhondup","year":"2017","unstructured":"Dhondup T, Qian Q (2017) Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif 43:179\u2013188","journal-title":"Blood Purif"},{"key":"3758_CR33","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1021\/jf304595p","volume":"61","author":"CL Hsieh","year":"2013","unstructured":"Hsieh CL, Peng CC, Chen KC, Peng RY (2013) Rutin (quercetin rutinoside) induced protein-energy malnutrition in chronic kidney disease, but quercetin acted beneficially. J Agric Food Chem 61:7258\u20137267","journal-title":"J Agric Food Chem"},{"key":"3758_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jff.2017.03.012","volume":"33","author":"V Diwan","year":"2017","unstructured":"Diwan V, Brown L, Gobe GC (2017) The flavonoid rutin improves kidney and heart structure and function in an adenine-induced rat model of chronic kidney disease. J Funct Foods 33:85\u201393","journal-title":"J Funct Foods"},{"key":"3758_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jtemb.2019.04.007","volume":"54","author":"C Caglayan","year":"2019","unstructured":"Caglayan C, Kandemir FM, Yildirim S, Kucukler S, Eser G (2019) Rutin protects mercuric chloride-induced nephrotoxicity via targeting of aquaporin 1 level, oxidative stress, apoptosis and inflammation in rats. J Trace Elem Med Biol 54:69\u201378","journal-title":"J Trace Elem Med Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03758-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:43:32Z","timestamp":1623368612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3758"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03758-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental procedure was approved by the Internal Research and Review Board, Ethical Clearance, Biosafety and Animal Welfare Committee of Madurai Kamaraj University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}